Remove Containment Remove Insulin Remove Medicine
article thumbnail

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

The Pharma Data

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52
article thumbnail

New Soliqua® data shows improved blood sugar control without weight gain versus premixed insulin

The Pharma Data

New Soliqua ® * data shows improved blood sugar control without weight gain versus premixed insulin. Study also shows more people on Soliqua had improved blood sugar control without weight gain and without low blood sugar events (hypoglycemia) in first head-to-head comparison with premixed insulin.

Insulin 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biologic Therapeutics Development, Part 1: Definition and Distinct Characteristics

Camargo

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. Essentially, a biologic is a product that is produced from living organisms or that contains components of living organisms.

article thumbnail

Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes | Eli Lilly and Company

The Pharma Data

The Tempo Pen is a modified version of Lilly ‘s existing prefilled, disposable insulin pen to which the Tempo Smart Button – pending CE (Conformité Européenne or European Conformity) marking – attaches. Diabetes is a chronic disease that occurs when the body does not properly produce or use the hormone insulin. About DexCom Inc.

Insulin 52
article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

It is all about what you can get at the lowest cost,” says Dr. Raymond Cross, director of the inflammatory bowel disease program at University of Maryland’s School of Medicine, Baltimore. For example, the first-to-market status was beneficial when it came to insulin biosimilars. …[but] for biosimilars, it is all about the money.

Marketing 262
article thumbnail

14 BEST IBS Medication Over The Counter

Druggist

Limit intake of processed food, which contain difficult to digest starch People who experience episodes of diarrhoea should avoid artificial sweeteners, which can cause a laxative effect. Antidepressants ( prescription-only medicines). Each single dose sachet of granules contains 3.5g Drugs to stop diarrhoea.

article thumbnail

Tackling diabetes & ALS with cell therapy

pharmaphorum

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral sclerosis (ALS) and diabetes. Even if you are treated with insulin and you are balanced, the body still may have experienced damage.

Insulin 126